Skip to main content
SpringerLink
Log in

Proton Beam Therapy for Hepatic Malignancies

  • Chapter
  • First Online:
Gastrointestinal Malignancies

Part of the book series: Practical Guides in Radiation Oncology ((PGRO))

  • 1090 Accesses

Abstract

Proton beam therapy (PBT) has emerged as a promising radiation treatment modality option for primary and metastatic hepatobiliary cancer patients due to its dosimetric advantages in sparing normal liver tissue from radiation. In this chapter, the rationale for using PBT for liver cancer patients, treatment planning and delivery including special considerations specific to PBT, and toxicities of liver PBT are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31(5):1237–48.

    Article  CAS  PubMed  Google Scholar 

  2. Cardenes HR, Price TR, Perkins SM, Maluccio M, Kwo P, Breen TE, et al. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol. 2010;12(3):218–25.

    Article  CAS  PubMed  Google Scholar 

  3. Huertas A, Baumann AS, Saunier-Kubs F, Salleron J, Oldrini G, Croise-Laurent V, et al. Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma. Radiother Oncol. 2015;115(2):211–6.

    Article  PubMed  Google Scholar 

  4. Ling TC, Kang JI, Bush DA, Slater JD, Yang GY. Proton therapy for hepatocellular carcinoma. Chin J Cancer Res. 2012;24(4):361–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lasley FD, Mannina EM, Johnson CS, Perkins SM, Althouse S, Maluccio M, et al. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy. Pract Radiat Oncol. 2015;5(5):e443–9.

    Article  PubMed  Google Scholar 

  6. Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Oshiro Y, Fukumitsu N, et al. Evaluation of liver function after proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(3):e529–35.

    Article  PubMed  Google Scholar 

  7. Dionisi F, Ben-Josef E. The use of proton therapy in the treatment of gastrointestinal cancers: liver. Cancer J. 2014;20(6):371–7.

    Article  CAS  PubMed  Google Scholar 

  8. Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2005;23(34):8739–47.

    Article  PubMed  Google Scholar 

  9. Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, et al. Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis. J Clin Oncol. 2016;34(3):219–26.

    Article  CAS  PubMed  Google Scholar 

  10. Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS, et al. Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2016;34(5):460–8.

    Article  CAS  PubMed  Google Scholar 

  11. Hata M, Tokuuye K, Sugahara S, Fukumitsu N, Hashimoto T, Ohnishi K, et al. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol. 2006;182(12):713–20.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hata M, Tokuuye K, Sugahara S, Kagei K, Igaki H, Hashimoto T, et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer. 2005;104(4):794–801.

    Article  PubMed  Google Scholar 

  13. Hata M, Tokuuye K, Sugahara S, Tohno E, Nakayama H, Fukumitsu N, et al. Proton beam therapy for aged patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2007;69(3):805–12.

    Article  PubMed  Google Scholar 

  14. Bush DA, Kayali Z, Grove R, Slater JD. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. Cancer. 2011;117(13):3053–9.

    Article  PubMed  Google Scholar 

  15. Fukumitsu N, Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Abei M, et al. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2009;74(3):831–6.

    Article  PubMed  Google Scholar 

  16. Mizumoto M, Tokuuye K, Sugahara S, Nakayama H, Fukumitsu N, Ohara K, et al. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int J Radiat Oncol Biol Phys. 2008;71(2):462–7.

    Article  PubMed  Google Scholar 

  17. Nakayama H, Sugahara S, Fukuda K, Abei M, Shoda J, Sakurai H, et al. Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract. Int J Radiat Oncol Biol Phys. 2011;80(4):992–5.

    Article  PubMed  Google Scholar 

  18. Hallman JL, Mori S, Sharp GC, Lu HM, Hong TS, Chen GT. A four-dimensional computed tomography analysis of multiorgan abdominal motion. Int J Radiat Oncol Biol Phys. 2012;83(1):435–41.

    Article  PubMed  Google Scholar 

  19. Park JC, Park SH, Kim JH, Yoon SM, Song SY, Liu Z, et al. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys. 2012;39(10):6431–42.

    Article  PubMed  Google Scholar 

  20. AAPM. AAPM Task Group 76. The management of respiratory motion in radiation oncology. AAPM Report No. 91. https://www.aapm.org/pubs/reports/rpt_91.pdf.

  21. Kang M, Huang S, Solberg T, Mayer R, Thomas A, Teo B, et al. TH-CD-209-08: quantification of the interplay effect in proton pencil beam scanning treatment of lung. Med Phys. 2016;43(6):3887.

    Article  Google Scholar 

  22. Shin D, Kim TH, Park SY, Kwak J, Moon SH, Yoon M, et al. Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2008;72(3):687–94.

    Article  CAS  PubMed  Google Scholar 

  23. Shirato H, Harada T, Harabayashi T, Hida K, Endo H, Kitamura K, et al. Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56(1):240–7.

    Article  PubMed  Google Scholar 

  24. Tanguturi SK, Wo JY, Zhu AX, Dawson LA, Hong TS. Radiation therapy for liver tumors: ready for inclusion in guidelines? Oncologist. 2014;19(8):868–79.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Schatti A, Zakova M, Meer D, Lomax AJ. The effectiveness of combined gating and re-scanning for treating mobile targets with proton spot scanning. An experimental and simulation-based investigation. Phys Med Biol. 2014;59(14):3813–28.

    Article  CAS  PubMed  Google Scholar 

  26. Yoon SS, Aloia TA, Haynes AB, Kambadakone A, Kaur H, Vauthey JN, et al. Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy. Pract Radiat Oncol. 2014;4(3):167–73.

    Article  PubMed  Google Scholar 

  27. Zhang Y, Huth I, Wegner M, Weber DC, Lomax AJ. An evaluation of rescanning technique for liver tumour treatments using a commercial PBS proton therapy system. Radiother Oncol. 2016;121(2):281–7.

    Article  PubMed  Google Scholar 

  28. Eccles C, Brock KK, Bissonnette JP, Hawkins M, Dawson LA. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006;64(3):751–9.

    Article  PubMed  Google Scholar 

  29. Kimura T, Hirokawa Y, Murakami Y, Tsujimura M, Nakashima T, Ohno Y, et al. Reproducibility of organ position using voluntary breath-hold method with spirometer for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60(4):1307–13.

    Article  PubMed  Google Scholar 

  30. Hong TS, DeLaney TF, Mamon HJ, Willett CG, Yeap BY, Niemierko A, et al. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. Pract Radiat Oncol. 2014;4(5):316–22.

    Article  PubMed  Google Scholar 

  31. Bush DA, Smith JC, Slater JD, Volk ML, Reeves ME, Cheng J, et al. Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysis. Int J Radiat Oncol Biol Phys. 2016;95(1):477–82.

    Article  PubMed  Google Scholar 

  32. Fukumitsu N, Okumura T, Takizawa D, Makishima H, Numajiri H, Murofushi K, et al. Proton beam therapy for metastatic liver tumors. Radiother Oncol. 2015;117(2):322–7.

    Article  PubMed  Google Scholar 

  33. Verma V, Lin SH, Simone CB II, Mehta MP. Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review. J Gastrointest Oncol. 2016;7(4):644–64.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Gandhi SJ, Liang X, Ding X, Zhu TC, Ben-Josef E, Plastaras JP, et al. Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: photons versus protons. Pract Radiat Oncol. 2015;5(4):209–18.

    Article  PubMed  Google Scholar 

  35. Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Hoyer M. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours. Acta Oncol. 2011;50(6):823–8.

    Article  PubMed  Google Scholar 

  36. Kim DY, Park JW, Kim TH, Kim BH, Moon SH, Kim SS, et al. Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis. Radiother Oncol. 2017;122(1):122–9.

    Article  PubMed  Google Scholar 

  37. Jabbour SK, Hashem SA, Bosch W, Kim TK, Finkelstein SE, Anderson BM, et al. Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus. Pract Radiat Oncol. 2014;4(2):82–9.

    Article  PubMed  Google Scholar 

  38. Apisarnthanarax S, Vyas S, Tseng T, St. James S. Interfractional geometric variation in gastrointestinal organs-at-risk: implications for planning organs-at-risk and hypofractionated proton therapy. Int J Radiat Oncol Biol Phys. 2016;96:S204.

    Article  Google Scholar 

  39. Fredriksson A, Forsgren A, Hardemark B. Minimax optimization for handling range and setup uncertainties in proton therapy. Med Phys. 2011;38(3):1672–84.

    Article  PubMed  Google Scholar 

  40. Unkelbach J, Bortfeld T, Martin BC, Soukup M. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. Med Phys. 2009;36(1):149–63.

    Article  PubMed  Google Scholar 

  41. Kawashima M, Kohno R, Nakachi K, Nishio T, Mitsunaga S, Ikeda M, et al. Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2011;79(5):1479–86.

    Article  PubMed  Google Scholar 

  42. Kawashima M, Furuse J, Nishio T, Konishi M, Ishii H, Kinoshita T, et al. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol. 2005;23(9):1839–46.

    Article  PubMed  Google Scholar 

  43. Ohkawa A, Mizumoto M, Ishikawa H, Abei M, Fukuda K, Hashimoto T, et al. Proton beam therapy for unresectable intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol. 2015;30(5):957–63.

    Article  PubMed  Google Scholar 

  44. Makita C, Nakamura T, Takada A, Takayama K, Suzuki M, Ishikawa Y, et al. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma. Radiat Oncol. 2014;9:26.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chuganji Y, Kagei K, et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res. 2005;11(10):3799–805.

    Article  PubMed  Google Scholar 

  46. Toesca DA, Osmundson EC, Eyben RV, Shaffer JL, Lu P, Koong AC, et al. Central liver toxicity after SBRT: An expanded analysis and predictive nomogram. Radiother Oncol. 2017;122(1):130–6.

    Article  PubMed  Google Scholar 

  47. Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Oshiro Y, Fukumitsu N, et al. Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys. 2011;81(4):1039–45.

    Article  PubMed  Google Scholar 

  48. Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2011;81(4):e447–53.

    Article  PubMed  Google Scholar 

  49. Nirula R, Mayberry JC. Rib fracture fixation: controversies and technical challenges. Am Surg. 2010;76(8):793–802.

    PubMed  Google Scholar 

  50. Kanemoto A, Mizumoto M, Okumura T, Takahashi H, Hashimoto T, Oshiro Y, et al. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma. Acta Oncol. 2013;52(3):538–44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Washington, Seattle, WA, USA

    Smith Apisarnthanarax M.D., Rosanna Yeung M.D., Stephen Bowen Ph.D. & Tobias R. Chapman M.D.

Authors
  1. Smith Apisarnthanarax M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosanna Yeung M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen Bowen Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tobias R. Chapman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Case Western Reserve University, Cleveland, Ohio, USA

    Suzanne Russo

  2. Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida, USA

    Sarah Hoffe

  3. Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington, USA

    Edward Kim

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Apisarnthanarax, S., Yeung, R., Bowen, S., Chapman, T.R. (2018). Proton Beam Therapy for Hepatic Malignancies. In: Russo, S., Hoffe, S., Kim, E. (eds) Gastrointestinal Malignancies. Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-64900-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64900-9_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64899-6

  • Online ISBN: 978-3-319-64900-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation